Giant cell hepatitis with autoimmune hemolytic anaemia (GCH-AHA) is a rare and aggressive disease of infancy and may have fatal prognosis. It is presumed to be an autoimmune disease, but the mechanism of liver injury is unknown. Immunosuppressive therapymay results in remission in mild forms while in severe forms, B cell depletion with rituximab can be an option. Liver transplantation may be a rescue treatment but relapse can occur in the graft.

L'epatite gigantocellulare associata ad anemia emolitica autoimmune

MAGGIORE, Giuseppe
Ultimo
2014

Abstract

Giant cell hepatitis with autoimmune hemolytic anaemia (GCH-AHA) is a rare and aggressive disease of infancy and may have fatal prognosis. It is presumed to be an autoimmune disease, but the mechanism of liver injury is unknown. Immunosuppressive therapymay results in remission in mild forms while in severe forms, B cell depletion with rituximab can be an option. Liver transplantation may be a rescue treatment but relapse can occur in the graft.
Nastasio, Silvia; Sciveres, Marco; Marsalli, Giulia; Maggiore, Giuseppe
File in questo prodotto:
File Dimensione Formato  
GCH-AHA GINGEP 14.pdf

solo gestori archivio

Tipologia: Full text (versione editoriale)
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 1.45 MB
Formato Adobe PDF
1.45 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11392/2370250
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact